Canopy Growth (CGC) Long-Term Investments (2018 - 2026)
Canopy Growth (CGC) reported Long-Term Investments of $78.8 million for Q1 2026, down 37.21% on a YoY basis from $125.4 million in Q1 2025, and down 29.21% sequentially from $111.3 million in Q4 2025.
Canopy Growth (CGC) Long-Term Investments (2018 - 2026) Analysis & Trends
Canopy Growth (CGC) has 9 years of Long-Term Investments data on file, last reported at $78.8 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments fell 37.21% year-over-year to $78.8 million; the trailing twelve-month figure through Mar 2026 stood at $78.8 million (down 37.21% YoY), and the FY2026 full-year result was $78.8 million, down 37.21% from the prior year.
- Long-Term Investments fell to $78.8 million in Q1 2026, from $111.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $324.8 million in Q1 2024 to a low of $24.2 million in Q4 2023.
- A 5-year average of $91.7 million and a median of $76.6 million in 2026 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments soared 692.78% in 2024 and sank 61.38% in 2025, its largest moves.
- Tracing CGC's Long-Term Investments over 5 years: stood at $27.3 million in 2022, then dropped by 11.07% to $24.2 million in 2023, then soared by 47.17% to $35.7 million in 2024, then soared by 211.87% to $111.3 million in 2025, then declined by 29.21% to $78.8 million in 2026.
- Business Quant data shows CGC's Long-Term Investments at $78.8 million in Q1 2026, $111.3 million in Q4 2025, and $137.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 78.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.76 Mn |
| Dec 31, 2025 | 111.26 Mn |
| Sep 30, 2025 | 137.38 Mn |
| Jun 30, 2025 | 116.85 Mn |
| Mar 31, 2025 | 125.43 Mn |
| Dec 31, 2024 | 35.67 Mn |
| Sep 30, 2024 | 99.97 Mn |
| Jun 30, 2024 | 110.16 Mn |
| Mar 31, 2024 | 324.77 Mn |
| Dec 31, 2023 | 24.24 Mn |
| Sep 30, 2023 | 57.44 Mn |
| Jun 30, 2023 | 74.48 Mn |
| Mar 31, 2023 | 40.97 Mn |
| Dec 31, 2022 | 27.26 Mn |
| Sep 30, 2022 | 55.21 Mn |
| Jun 30, 2022 | 47.06 Mn |
| Mar 31, 2021 | 79,009.91 |
| Dec 31, 2020 | 13.03 Mn |
| Sep 30, 2020 | 19.26 Mn |
| Jun 30, 2020 | 42.30 Mn |